Zeitlberger, A. M.
Putora, P. M.
Hofer, S.
Schucht, P.
Migliorini, D.
Hottinger, A. F.
Roelcke, U.
Läubli, H.
Spina, P.
Bozinov, O.
Weller, M.
Neidert, M. C.
Hundsberger, T. http://orcid.org/0000-0002-4419-2767
Funding for this research was provided by:
Bayer AG
Article History
Received: 7 March 2022
Accepted: 20 April 2022
First Online: 29 April 2022
Declarations
:
: MW has received research grants from Apogenix, Merck, Sharp & Dohme, Merck (EMD), Philogen and Quercis, and honoraria for lectures or advisory board participation or consulting from Adastra, Bayer, Bristol Meyer Squibb, Medac, Merck, Sharp & Dohme, Merck (EMD), Nerviano Medical Sciences, Novartis, Orbus and Philogen. HL received travel grants and consultant fees from Bristol-Myers Squibb (BMS) and Merck, Sharp and Dohme (MSD) and received research support from BMS, Novartis, GlycoEra and Palleon Pharmaceuticals. MCN has received a research grant from Novocure, honoraria for consulting or lectures from WISE and MSD. On behalf of all other authors, the corresponding author states that there is no conflict of interest.
: Not applicable.
: Not applicable.